CAMBRIDGE NUTRITIONAL SCIENCES PLC ORD GBP0.04

Symbol: CNSL

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date Unknown
Pay Date Unknown
Total Dividends - Year to Date0
Dividend Yield (%)0

Historical Data & Ratios

Avg Volume Over 10 Days0.1334
Market Cap (M)6.4247
Price/Earnings (PE)53
Earnings Per Share0.05
Revenue Per Share0.0411
Return on Equity %-3.3413

1 Month Performance Chart

One Month Chart

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here
0.30%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      Cambridge Nutritional Sciences plc is a United Kingdom-based diagnostics testing company. The principal activities of the Company are the manufacture, development and distribution of medical diagnostics products for the food sensitivity testing market. The Company’s segments include Health and Nutrition, and Corporate. The Health and Nutrition division specializes in the research, development and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis for the general public, clinics and health professionals as well as supplying the point-of-care Food Detective test. Its range of food sensitivity and functional health tests can help identify the root cause of gut health issues. Its brands include FoodPrint, Food Detective, CNSLab, and My Health Tracker. The Company has a global customer base across more than 75 countries, and its products are used by more than 170 laboratories worldwide.

      Financial Summary

      BRIEF: For the six months ended 30 September 2024, Cambridge Nutritional Sciences PLC revenues decreased 16% to £4.1M. Net loss decreased 72% to £196K. Revenues reflect North America segment decrease of 39% to £628K, Rest of Europe segment decrease of 18% to £952K, Africa/Middle East segment decrease of 20% to £408K. Lower net loss reflects Health and Nutrition segment income increase of 41% to £500K.

      Financials


      Income Statement - All values are in GBP (M).

      Year Ending

      31/03/2024

      31/03/2023

      31/03/2022

      31/03/2021

      31/03/2020

      31/03/2019

      Total Revenue 9.77 7.55 8.54 8.73 9.82 8.76
      Gross profit 6.05 3.55 5.10 4.46 6.29 5.63
      Operating Profit/Loss -0.77 -3.24 -0.93 -3.32 -8.05 -0.27
      Profit Before Tax -0.75 -3.25 -0.95 -3.54 -8.30 -0.37
      Profit After Tax -0.33 -3.17 -1.41 -2.10 -6.83 -0.34
      Equity Holders of Parent Company -0.33 -3.86 -11.33 -2.10 -6.83 0.97
      Minority Interest NIL NIL NIL NIL NIL NIL


      Balance Sheet - All values are in GBP (M).

      Year Ending

      31/03/2024

      31/03/2023

      31/03/2022

      31/03/2021

      31/03/2020

      31/03/2019

      Total Non-Current Assets 6.02 6.11 12.09 18.75 14.38 19.99
      Total Current Assets 7.88 8.30 5.74 12.24 4.46 3.49
      Total Assets 13.89 14.41 17.84 30.99 18.84 23.48
      Total Liabilities 4.21 4.45 6.02 7.32 5.23 5.28
      Total Net Assets 9.68 9.95 11.82 23.67 13.61 18.19
      Shareholders Funds 9.68 9.95 11.82 23.67 13.61 18.19
      Minority Interests NIL NIL NIL NIL NIL NIL
      Total Equity 9.68 9.95 11.82 23.67 13.61 18.19

      Outlook

      Sorry, broker view information on this investment is not available at this time.

      Time & Sales

      All prices are in GBX and times are in GMT. Last 20 trades shown. Trade type is estimated and should be treated as indicative only.

      Date Time Price Volume Type
      7 May 2025 11:23 2.478 1,697 Sell
      7 May 2025 11:01 2.478 3,909 Sell
      7 May 2025 11:00 2.64 27,000 Buy
      7 May 2025 10:21 2.7 200 Buy
      7 May 2025 10:21 2.55 80,519 Sell
      7 May 2025 09:58 2.55 72,500 Sell
      7 May 2025 09:01 2.55 482 Sell
      6 May 2025 15:03 2.64 49,393 Sell
      6 May 2025 14:34 2.55 12,500 Sell
      6 May 2025 13:39 2.64 21,592 Sell
      6 May 2025 12:24 2.5642 45,886 Sell
      6 May 2025 11:56 2.64 20,742 Sell
      6 May 2025 08:37 2.552 6,573 Sell
      6 May 2025 08:29 2.55 577 Sell
      6 May 2025 08:20 2.5642 30,688 Sell
      2 May 2025 16:27 2.75 4,036 Buy
      2 May 2025 14:33 2.64 37,727 Sell
      2 May 2025 13:36 2.55 3,519 Sell
      2 May 2025 13:24 2.552 6,000 Sell

      Selected data supplied by Thomson Reuters ©  View restrictions.

      Investment involves risk. You may get back less than invested.